action of glp-1 agonist Mechanism of [25] Frontiers | GLP−1 receptor agonists

If intramuscular administration is suspected, the washout periods for the intramuscular route should be observed

The most frequently reported experience involves a temporary increase in hunger during weeks two through four after switching

Additionally, if the FDA approves more uses for these medicines, insurance companies will be less likely to object to prescribing GLP-1s for uses beyond diabetes and weight loss

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes

Diabetes: from research to clinical practice: Volume 4 [Internet]